Whitehawk Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO David J. Lennon, with a market cap of $198.2M.
Common questions about Whitehawk Therapeutics, Inc. Common Stock
Whitehawk Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open.
We use cookies for analytics. See our Privacy and Cookie Policy.